Month: April 2023

SOUTH ORANGE, NJ, April 04, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced preliminary revenue results for the quarter ended March 31, 2023. Nephros expects net revenue for the quarter ended March 31, 2023 to be approximately $3.7 million, a 69% increase from the quarter ended March 31, 2022. “We are very pleased with first-quarter revenue, which we believe reflects the impact of recent investments in our field sales organization,” said Andy Astor, President and Chief Executive Officer of Nephros. “It is noteworthy that while this quarter’s revenue was enhanced by an unusually large emergency response order, our base revenue is expected to exceed $3.0 million, representing an approximate...

Figure 1 Gooseberry CSAMT with Vein Interpretations and Proposed Phase II DrillingVANCOUVER, British Columbia, April 04, 2023 (GLOBE NEWSWIRE) — American Pacific Mining Corp (CSE: USGD / OTCQX: USGDF / FWB: 1QC) (“American Pacific” or the “Company”) is pleased to announce that it has commenced drilling at its Gooseberry Silver Project in Nevada. The planned 15 hole, up to 3048 metre (10,000 feet) Phase II drill program will focus on testing the extension of the Gooseberry Vein as well as the Elderberry and Strawberry Zones (Figure 1)—new targets that were generated in 2022 through analysis of soil geochemistry, clay spectral imagery, mapping and integrated controlled source audio-frequency magnetotellurics (“CSAMT”) geophysics completed in 2022. “Exploration data that we compiled, including CSAMT geophysics, soil geochemistry...

Patient enrollment to commence Carlsbad, Calif., April 04, 2023 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB:ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has received Institutional Review Board (IRB) multi-site selection approval for its new multicenter study of DEXA-C™ Cervical Interbody System. The study has selected seven sites with three submitted for approval. After approval, patient enrollment is expected to begin. The study will initially include data from 40 single level and 40 multiple level subjects. The DEXA-C system is indicated for anterior cervical interbody fusion procedures and is the first in a series of implants based on Aurora’s patented DEXA™ technology platform. Based...

Blue Arc CARB certification The Shyft Group has completed testing and received an executive order of compliance from the California Air Resources Board (CARB) for the Company’s Blue Arc™ EV Solutions Class 3, 4 and 5 electric delivery vehicles. Together with Shyft’s recent announcement on EPA testing citing up to 200 mile range city/highway combined, the executive order and certification are important milestones that help clear the way for Shyft’s Blue Arc vans to start production later this year and be sold in all 50 states.Blue Arc EVs meet emission standards set by the California Air Resources Boardand contribute to cleaner, safer air quality 225-mile city driving range exceeds fleet customer demand NOVI, Mich., April 04, 2023 (GLOBE NEWSWIRE) — The Shyft Group, Inc. (NASDAQ: SHYF), the North American leader in specialty...

CAMBRIDGE, Mass., April 04, 2023 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced the appointment of Adam Keeney, Ph.D., as Executive Vice President, Head of Corporate Development effective 17 April 2023. Dr. Keeney will be a member of Biogen’s Executive Committee reporting to Christopher A. Viehbacher, President and Chief Executive Officer. “We welcome Adam Keeney to our executive leadership team in this important role at this pivotal time for Biogen. Adam brings considerable experience in biopharmaceutical strategy and business development with a solid track record of value-creating deals throughout his career,” said Mr. Viehbacher. “As we are working to put Biogen on a sustainable growth trajectory, Adam will focus on advancing the company’s strategy and pursuing external collaborations and other growth opportunities.” Dr....

NORWOOD, Mass., April 04, 2023 (GLOBE NEWSWIRE) — MariMed Inc. (CSE: MRMD), (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator, today announced that its wholly owned subsidiary, Kind Therapeutics USA, has received approval from the Maryland Medical Cannabis Commission (“MMCC”) to immediately begin producing and distributing higher-dosage, THC-infused edibles. Maryland cannabis regulations changed in 2021, imposing a THC limit of 10 milligrams per edible serving unless the product was produced and distributed from a Good Manufacturing Practice (“GMP”) certified kitchen. GMP certification is a process conducted by third-party auditors that ensures a commercial kitchen and the products created there meet the highest standards for health and safety. When the Company’s Hagerstown, Maryland, production...